These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 15373581)

  • 1. Development of anti-Bw6 reactivity in patients receiving r-GCSF: a preliminary report.
    Leach MF; Aubuchon JP
    Immunohematology; 2001; 17(3):63-9. PubMed ID: 15373581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet antibody screening by flow cytometry is more sensitive than solid phase red cell adherence assay and lymphocytotoxicity technique: a comparative study in Thai patients.
    Buakaew J; Promwong C
    Asian Pac J Allergy Immunol; 2010; 28(2-3):177-84. PubMed ID: 21038788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients.
    Benedetti G; Patoia L; Giglietti A; Alessio M; Pelicci P; Grignani F
    Bone Marrow Transplant; 1999 Nov; 24(9):971-9. PubMed ID: 10556956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful management of alloimmunized patients by transfusing HLA compatible and crossmatched platelets.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Mou LL; Deng JM
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Apr; 47(4):228-36. PubMed ID: 1646671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of platelet-specific antibodies and efficacy of crossmatch-compatible platelet transfusions in refractory patients.
    Jia Y; Li W; Liu N; Zhang K; Gong Z; Li D; Wang L; Wang D; Jing Y; Wang J; Shan X
    Transfus Med; 2014 Dec; 24(6):406-10. PubMed ID: 25327352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombocytopenia after high-dose chemotherapy and autologous stem cell transplantation: an unresolved problem and possible approaches to resolve it.
    Hassan HT; Zander AR
    J Hematother; 1996 Aug; 5(4):407-14. PubMed ID: 8877716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of G-CSF or GM-CSF mobilized peripheral blood progenitor cells (PBPC) alone or to augment marrow as hematologic support of single or multiple cycle high-dose chemotherapy.
    Elias AD; Ayash L; Tepler I; Wheeler C; Schwartz G; Mazanet R; Schnipper L; Frei E; Antman K
    J Hematother; 1993; 2(3):377-82. PubMed ID: 7522891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a solid phase red cell adherence technique for platelet antibody screening.
    Lown JA; Ivey JG
    Transfus Med; 1991 Sep; 1(3):163-7. PubMed ID: 9259843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Thrombocyte transfusion: increase in platelets in relation to clinical and immunologic prerequisites].
    Panzer S; Maier F; Höcker P; Mayr WR; Hinterberger W
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():10-4. PubMed ID: 3298059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet transfusions are associated with the development of anti-major histocompatibility complex class I antibodies in patients with left ventricular assist support.
    Moazami N; Itescu S; Williams MR; Argenziano M; Weinberg A; Oz MC
    J Heart Lung Transplant; 1998 Sep; 17(9):876-80. PubMed ID: 9773859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of antibody response to human platelet transfusion.
    Wu KK; Thompson JS; Koepke JA; Hoak JC; Flink R
    J Clin Invest; 1976 Aug; 58(2):432-8. PubMed ID: 956376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The changing face of stem cell transplantation by the use of recombinant human granulocyte colony stimulating factor.
    Boogaerts MA; Demuynck H
    Eur J Cancer; 1994; 30A Suppl 3():S34-9. PubMed ID: 7535071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
    Oza A; Hallemeier C; Goodnough L; Khoury H; Shenoy S; Devine S; Augustin K; Vij R; Trinkaus K; Dipersio JF; Adkins D
    Transfusion; 2006 Jan; 46(1):14-23. PubMed ID: 16398726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of drug-dependent, platelet-reactive antibodies by solid-phase red cell adherence assays.
    Leach MF; Cooper LK; AuBuchon JP
    Br J Haematol; 1997 Jun; 97(4):755-61. PubMed ID: 9217173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience.
    Olivieri A; Offidani M; Montanari M; Ciniero L; Cantori I; Ombrosi L; Masia CM; Centurioni R; Mancini S; Brunori M; Leoni P
    Haematologica; 1998 Apr; 83(4):329-37. PubMed ID: 9592983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation.
    Bence-Bruckler I; Bredeson C; Atkins H; McDiarmid S; Hamelin L; Hopkins H; Perry G; Genest P; Huebsch L
    Bone Marrow Transplant; 1998 Nov; 22(10):965-9. PubMed ID: 9849693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
    Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
    Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet transfusion requirements during autologous peripheral blood progenitor cell transplantation correlate with the pretransplant platelet count.
    Bolwell BJ; Goormastic M; Andresen S; Overmoyer B; Pohlman B; Kalaycio M
    Bone Marrow Transplant; 1997 Sep; 20(6):459-63. PubMed ID: 9313878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An evaluation of platelet transfusion response using HLA crossmatch-compatible donors in patients with platelet refractoriness].
    Hyun J; Lim YM; Park KD; Han BY; Kim YH; Han KS; Park MH
    Korean J Lab Med; 2009 Oct; 29(5):481-9. PubMed ID: 19893359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.